Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-06-11 Sale |
2024-06-13 5:33 pm |
Mineralys Therapeutics Inc. | MLYS | Levy Adam Scott CFO and Secretary |
96,815 | $12.94 | $1,252,718 | 255,462 (Direct) |
View |
| 2024-05-09 Sale |
2024-05-10 4:17 pm |
Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer |
100 | $15 | $1,500 | 270,051 (Direct) |
View |
| 2024-02-12 Purchase |
2024-02-14 9:06 pm |
Mineralys Therapeutics Inc. | MLYS | Samsara BioCapital GP LLC Samsara BioCapital L.P. 10% Owner |
555,555 | $13.5 | $7,499,993 | 5,074,916 (Indirect) |
View |
| 2023-11-22 Purchase |
2023-11-27 4:01 pm |
Mineralys Therapeutics Inc. | MLYS | Congleton Jon Chief Executive Officer |
4,250 | $5.9661 | $25,356 | 1,049,068 (Direct) |
View |
| 2023-09-06 Purchase |
2023-09-08 08:49 am |
Mineralys Therapeutics Inc. | MLYS | Congleton Jon Chief Executive Officer |
2,250 | $12.08 | $27,180 | 1,044,818 (Direct) |
View |
| 2023-08-17 Purchase |
2023-08-21 4:03 pm |
Mineralys Therapeutics Inc. | MLYS | Congleton Jon Chief Executive Officer |
2,250 | $12.1 | $27,225 | 1,042,568 (Direct) |
View |
| 2023-08-10 Sale |
2023-08-11 7:11 pm |
Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer |
231,716 | $12.92 | $2,994,401 | 480,043 (Direct) |
View |
| 2023-08-11 Purchase |
2023-08-11 7:11 pm |
Mineralys Therapeutics Inc. | MLYS | Congleton Jon Chief Executive Officer |
2,000 | $12.89 | $25,780 | 1,040,318 (Direct) |
View |
| 2023-02-14 Purchase |
2023-02-16 9:00 pm |
Mineralys Therapeutics Inc. | MLYS | HBM Healthcare Investments (Cayman) Ltd. 10% Owner |
312,500 | $16 | $5,000,000 | 3,218,106 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-11 Exercise |
2024-06-13 5:32 pm |
N/A 2031-03-11 |
Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer |
11,366 | $0 | 315,207 (Direct) |
View |
| 2024-06-12 Exercise |
2024-06-13 5:32 pm |
N/A N/A |
Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer |
6,349 | $1.08 | 315,207 (Direct) |
View |
| 2024-06-11 Exercise |
2024-06-13 5:32 pm |
N/A N/A |
Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer |
5,017 | $0.54 | 315,207 (Direct) |
View |
| 2024-05-22 Option Award |
2024-05-28 6:51 pm |
N/A 2034-05-22 |
Mineralys Therapeutics Inc. | MLYS | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director |
22,000 | $0 | 22,000 (Indirect) |
View |
| 2024-05-22 Option Award |
2024-05-23 4:22 pm |
N/A 2034-05-22 |
Mineralys Therapeutics Inc. | MLYS | DiRocco Derek Director |
22,000 | $0 | 22,000 (Direct) |
View |
| 2024-05-22 Option Award |
2024-05-23 4:22 pm |
N/A 2034-05-22 |
Mineralys Therapeutics Inc. | MLYS | SBLENDORIO GLENN Director |
22,000 | $0 | 22,000 (Direct) |
View |
| 2024-05-22 Option Award |
2024-05-23 4:21 pm |
N/A 2034-05-22 |
Mineralys Therapeutics Inc. | MLYS | AKKARAJU SRINIVAS Samsara BioCapital L.P. Director 10% Owner |
22,000 | $0 | 22,000 (Direct) |
View |
| 2024-05-22 Option Award |
2024-05-23 4:21 pm |
N/A 2034-05-22 |
Mineralys Therapeutics Inc. | MLYS | Karydas Daphne Director |
22,000 | $0 | 22,000 (Direct) |
View |
| 2024-05-22 Option Award |
2024-05-23 4:21 pm |
N/A 2034-05-22 |
Mineralys Therapeutics Inc. | MLYS | Slingsby Brian Taylor Catalys Pacific Fund LP Director 10% Owner |
22,000 | $0 | 22,000 (Direct) |
View |
| 2024-05-22 Option Award |
2024-05-23 4:20 pm |
N/A 2034-05-22 |
Mineralys Therapeutics Inc. | MLYS | Litzka Olivier Director |
22,000 | $0 | 22,000 (Direct) |
View |
| 2024-05-13 Exercise |
2024-05-15 4:43 pm |
N/A 2031-03-11 |
Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer |
11,366 | $0 | 315,207 (Direct) |
View |
| 2024-05-13 Exercise |
2024-05-15 4:43 pm |
N/A N/A |
Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer |
6,348 | $1.08 | 315,207 (Direct) |
View |
| 2024-05-13 Exercise |
2024-05-15 4:43 pm |
N/A N/A |
Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer |
5,018 | $0.54 | 315,207 (Direct) |
View |
| 2024-05-09 Exercise |
2024-05-10 4:17 pm |
N/A 2031-07-11 |
Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer |
100 | $0 | 270,051 (Direct) |
View |
| 2024-05-09 Exercise |
2024-05-10 4:17 pm |
N/A N/A |
Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer |
100 | $1.08 | 270,051 (Direct) |
View |
| 2024-04-11 Exercise |
2024-04-15 4:24 pm |
N/A 2031-03-11 |
Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer |
11,366 | $0 | 315,307 (Direct) |
View |
| 2024-04-12 Exercise |
2024-04-15 4:24 pm |
N/A N/A |
Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer |
6,349 | $1.08 | 315,307 (Direct) |
View |
| 2024-04-11 Exercise |
2024-04-15 4:24 pm |
N/A N/A |
Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer |
5,017 | $0.54 | 315,307 (Direct) |
View |
| 2024-03-11 Exercise |
2024-03-13 5:35 pm |
N/A 2031-03-11 |
Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer |
11,365 | $0 | 315,307 (Direct) |
View |
| 2024-03-12 Exercise |
2024-03-13 5:35 pm |
N/A N/A |
Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer |
6,348 | $1.08 | 315,307 (Direct) |
View |
| 2024-03-11 Exercise |
2024-03-13 5:35 pm |
N/A N/A |
Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer |
5,017 | $0.54 | 315,307 (Direct) |
View |
| 2024-02-13 Option Award |
2024-02-15 4:26 pm |
N/A 2034-02-13 |
Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer |
200,000 | $0 | 200,000 (Direct) |
View |
| 2024-02-13 Option Award |
2024-02-15 4:26 pm |
N/A 2034-02-13 |
Mineralys Therapeutics Inc. | MLYS | Levy Adam Scott CFO and Secretary |
200,000 | $0 | 200,000 (Direct) |
View |
| 2024-02-13 Option Award |
2024-02-15 4:26 pm |
N/A 2034-02-13 |
Mineralys Therapeutics Inc. | MLYS | Congleton Jon Chief Executive Officer |
425,000 | $0 | 425,000 (Direct) |
View |
| 2024-02-12 Option Award |
2024-02-14 9:07 pm |
N/A N/A |
Mineralys Therapeutics Inc. | MLYS | AKKARAJU SRINIVAS Director 10% Owner |
555,555 | $13.5 | 5,074,916 (Indirect) |
View |
| 2024-02-12 Option Award |
2024-02-14 7:49 pm |
N/A N/A |
Mineralys Therapeutics Inc. | MLYS | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director |
1,672,508 | $13.5 | 5,400,739 (Indirect) |
View |
| 2024-02-12 Option Award |
2024-02-14 7:49 pm |
N/A N/A |
Mineralys Therapeutics Inc. | MLYS | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director |
549,755 | $13.5 | 5,400,739 (Indirect) |
View |
| 2024-02-12 Exercise |
2024-02-13 4:08 pm |
N/A 2031-03-11 |
Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer |
11,366 | $0 | 315,307 (Direct) |
View |
| 2024-02-12 Exercise |
2024-02-13 4:08 pm |
N/A N/A |
Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer |
6,349 | $1.08 | 315,307 (Direct) |
View |
| 2024-02-12 Exercise |
2024-02-13 4:08 pm |
N/A N/A |
Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer |
5,017 | $0.54 | 315,307 (Direct) |
View |
| 2024-01-11 Exercise |
2024-01-12 4:01 pm |
N/A 2031-03-11 |
Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer |
11,365 | $0 | 315,307 (Direct) |
View |
| 2024-01-12 Exercise |
2024-01-12 4:01 pm |
N/A N/A |
Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer |
6,348 | $1.08 | 315,307 (Direct) |
View |
| 2024-01-11 Exercise |
2024-01-12 4:01 pm |
N/A N/A |
Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer |
5,017 | $0.54 | 315,307 (Direct) |
View |
| 2023-12-11 Exercise |
2023-12-12 5:08 pm |
N/A 2031-03-11 |
Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer |
5,018 | $0 | 85,293 (Direct) |
View |
| 2023-12-11 Exercise |
2023-12-12 5:08 pm |
N/A N/A |
Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer |
5,018 | $0.54 | 85,293 (Direct) |
View |
| 2023-11-13 Exercise |
2023-11-14 6:18 pm |
N/A 2031-03-11 |
Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer |
5,017 | $0 | 85,293 (Direct) |
View |
| 2023-11-13 Exercise |
2023-11-14 6:18 pm |
N/A N/A |
Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer |
5,017 | $0.54 | 85,293 (Direct) |
View |
| 2023-11-03 Exercise |
2023-11-07 5:15 pm |
N/A 2031-03-11 |
Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer |
10,034 | $0 | 85,293 (Direct) |
View |
| 2023-11-03 Exercise |
2023-11-07 5:15 pm |
N/A N/A |
Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer |
10,034 | $0.54 | 85,293 (Direct) |
View |
| 2023-09-13 Option Award |
2023-09-14 4:13 pm |
N/A 2033-09-13 |
Mineralys Therapeutics Inc. | MLYS | Karydas Daphne Director |
44,000 | $0 | 44,000 (Direct) |
View |
| 2023-09-13 Option Award |
2023-09-14 4:13 pm |
N/A 2033-09-13 |
Mineralys Therapeutics Inc. | MLYS | SBLENDORIO GLENN Director |
44,000 | $0 | 44,000 (Direct) |
View |
| 2023-08-10 Exercise |
2023-08-11 7:11 pm |
N/A 2031-03-11 |
Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer |
231,716 | $0 | 480,043 (Direct) |
View |
| 2023-08-11 Exercise |
2023-08-11 7:11 pm |
N/A N/A |
Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer |
76,182 | $1.08 | 480,043 (Direct) |
View |
| 2023-08-10 Exercise |
2023-08-11 7:11 pm |
N/A N/A |
Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer |
155,534 | $0.54 | 480,043 (Direct) |
View |
| 2023-07-12 Other |
2023-07-14 08:55 am |
N/A 2033-02-09 |
Mineralys Therapeutics Inc. | MLYS | Takahashi Takeshi Director |
44,000 | $0 | 0 (Direct) |
View |
| 2023-07-12 Other |
2023-07-14 08:55 am |
N/A 2033-02-09 |
Mineralys Therapeutics Inc. | MLYS | Slingsby Brian Taylor Catalys Pacific Fund LP Director 10% Owner |
132,000 | $0 | 88,000 (Direct) |
View |
| 2023-04-27 Other |
2023-05-01 4:06 pm |
N/A 2033-02-09 |
Mineralys Therapeutics Inc. | MLYS | Litzka Olivier Director |
44,000 | $0 | 0 (Direct) |
View |
| 2023-03-17 Option Award |
2023-03-21 6:48 pm |
N/A 2033-03-17 |
Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer |
20,000 | $0 | 20,000 (Direct) |
View |
| 2023-03-17 Option Award |
2023-03-21 6:48 pm |
N/A 2033-03-17 |
Mineralys Therapeutics Inc. | MLYS | Congleton Jon Chief Executive Officer |
99,800 | $0 | 99,800 (Direct) |
View |
| 2023-03-17 Option Award |
2023-03-21 6:47 pm |
N/A 2033-03-17 |
Mineralys Therapeutics Inc. | MLYS | Levy Adam Scott CFO and Secretary |
20,000 | $0 | 20,000 (Direct) |
View |
| 2023-02-14 Conversion |
2023-02-16 9:00 pm |
N/A N/A |
Mineralys Therapeutics Inc. | MLYS | HBM Healthcare Investments (Cayman) Ltd. 10% Owner |
34,280,347 | $0 | 3,218,106 (Direct) |
View |